Format

Send to:

Choose Destination
See comment in PubMed Commons below
AJR Am J Roentgenol. 2011 Oct;197(4):789-94. doi: 10.2214/AJR.11.7656.

Percutaneous tumor ablation for hepatocellular carcinoma.

Author information

  • 1Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, White 270, 55 Fruit St, Boston, MA 02214, USA. dgervais@partners.org

Abstract

OBJECTIVE:

This report reviews the current clinical status of percutaneous ablation of hepatocellular carcinoma (HCC).

CONCLUSION:

HCC is increasing in incidence. Multiple percutaneous ablation methods are now available for primary treatment or for bridging to transplantation. Percutaneous ethanol instillation and radiofrequency ablation are the most extensively evaluated percutaneous treatments for HCC. Newer technologies are being evaluated and may change future practice patterns.

PMID:
21940565
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk